Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1016/j.bjan.2013.04.007
Brazilian Journal of Anesthesiology
Scientific Article

Metoclopramida e ondansetrona alteram o bloqueio neuromuscular induzido por mivacúrio? - um estudo randomizado

Do metoclopramide and ondansetrone alter mivacurium-induced neuromuscular blockade? - a randomised trial

Mehmet Tercan; Esra Mercanoglu Efe; Gurkan Turker; Fatma Nur Kaya; Belgin Yavascaoglu; Yesim Ozarda; Elif Basagan Mogol

http://dx.doi.org/10.1016/j.bjan.2013.04.007 Braz J Anesthesiol, vol.64, n1, p.35-39, 2014
PDF Português
PDF English
Downloads: 0
Views: 696

Resumo

Experiência: Objetivamos investigar os efeitos de metoclopramida e ondansetrona no bloqueio neuromuscular por mivacúrio. Métodos: Foram incluídos no estudo 75 pacientes ASA I-II, com idades entre 18 e 65 anos e agendados para cirurgia eletiva necessitando de intubação traqueal. Os pacientes receberam metoclopramida 10 mg, ondansetrona 4 mg ou salina normal 5 mL; grupo M, grupo O e grupo SN (n = 25) respectivamente. Antes da anestesia, os medicamentos em estudo foram administrados em um volume de 5 mL. O nível de colinesterase plasmática foram obtidos antes e 5 minutos depois da administração dos medicamentos em estudo e 5 minutos depois da administração de mivacúrio. Os tempos até o início e os níveis T25, T75, T25-75 e T90 foram comparados entre si, tendo sido investigadas as diferenças entre cada paciente. Depois de registrar T90, o estudo foi terminado, tendo início a cirurgia. Resultados: O tempo até o início foi significativamente mais breve no Grupo M versus os outros dois grupos. O tempo até o início no Grupo O foi significativamente mais breve versus grupo SN. No grupo M, T25, T75, T90 e os índices de recuperação foram significativamente maiores versus Grupo NS (p < 0,001). No Grupo O, T25 e T75 foram maiores versus Grupo NS (p < 0,01 e p < 0,05,respectivamente). No Grupo M, T75, T90 e índices de retorno da anestesia foram significativamente maiores versus Grupo O (p < 0,001, p < 0,01, p < 0,001, respectivamente). Nos Grupos M e O, os níveis plasmáticos de colinesterase diminuíram significativamente (p < 0,001). Depois da administração dos medicamentos em estudo e de mivacúrio. Houve também redução na colinesterase plasmática no Grupo NS 5 minutos após a administração de mivacúrio (p < 0,001). Conclusão: Consideramos que ondansetrona seja agente mais confiável do que metoclopramida, quando utilizada com mivacúrio.

Palavras-chave

Mivacúrio, Metoclopramida, Ondansetrona, Neuromuscular, Bloqueio, Anestesia

Abstract

Background: We aimed to investigate the effects of metoclopramide and ondansetrone on mivacurium neuromuscular blockade. Methods: Seventy five, ASA I-II patients, aged 18-65 and scheduled for elective surgery requiring tracheal intubation were included in the study. The patients received metoclopramide 10 mg, ondansetrone 4 mg or normal saline 5 mL; group M, group O, group NS (n = 25), respectively. Before anesthesia study drugs were administered in a volume of 5 mL. The level of plasma cholinesterase were obtained before and 5 minutes after the administration of study drugs and5 minutes after the administration of mivacurium. Onset time, T25, T75, T25-75, T90 levelswere compared with each other and differences between each patients were investigated. After recording T90, the study was terminated and surgery was started. Results: Onset time was significantly shorter in group M, than the other two groups. Onset time in group O was significantly shorter than in group NS. In Group M T25, T75, T90 and recovery indices were significantly greater than in Group NS (p < 0.001). In Group O T25, T75 were greater than Group NS (p < 0.01 and p < 0.05, respectively). In Group M T75, T90 and emergence indices were significantly higher than Group O (p < 0.001, p < 0.01, p < 0.001, respectively). In Groups M and O, plasma cholinesterase levels decreased significantly (p < 0.001) after administration of study drugs and mivacurium. Plasma cholinesterase also was reduced in Group NS 5 minutes after the administration of mivacurium (p < 0.001). Conclusion: Ondansetrone is believed to be more reliable agent than metoclopramide when used with mivacurium.

Keywords

Mivacurium, Metoclopramide, Ondansetrone, Neuromusculary, Blockade, Anesthesia

References

Savarese JJ, Ali HH, Basta SJ. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U): a short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology. ;68:732-723.

Cook DR, Stiller RL, Weakly JN. In vitro metabolism of mivacurium chloride (BWB1090U) and succinylcholine. Anaesth Analg. ;68:452-456.

Henzi I, Walder B, Tramer MR. Metaclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomised placebo-controlled studies. Br J Anaesth. ;83:761-767.

Perel MS, Moore C, Hersh T. Metoclopramide therapy in patients with delayed gastric emptying: a randomised double blind study. Dig Dis Sci. ;24:666-662.

Wright RA, Clemente R, Wathen R. Diabetic gastroparesis: an abnormality of gastric emptying of solids. Am J Med Sci. ;289:240-243.

Brock-Utne JG, Dow TGB, Welman S. The effect of metoclopramide on lower oesophageal tone in late pregnancy. Anaesth Int Care. ;6:26-29.

Kao YJ, Tellez J, Turner DR. Dose-dependent effect of metoclopramide on cholinesterases and suxamethonium metabolism. Br J Anaesth. ;65:224-220.

Skinner HJ, Girling KJ, Whitehurst A, Nathanson MH. Influence of metoclopramide on plasma cholinesterase and duration of action of mivacurium. Br J Anaesth. ;82:542-545.

Nijs N, Duvaldestin P, Slavov V. Is the recovery profile of mivacurium independent of the rate of decay of its plasma concentration in patients with normal plasma cholinesterase activity?. Acta Anaesthesiol Scand. ;42:1175-1179.

Cubeddu LX, Hoffman IS, Fuenmayor NT. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin induced nausea and vomiting. N Engl J Med. ;322:810-816.

Richardson BP, Engel G, Donarsch P. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature. ;316:131-126.

Fozard JR. Neuronal 5-HT receptors in the periphery. Neuropharmacology. ;23:1473-1486.

Kilpatrick GJ, Jones BJ, Tyers MB. Identification and distribution of 5-HT3 receptors in the rat brain using radioligand binding. Nature. ;330:748-746.

Lien CA, Gadalla F, Kudlak TT. The effect of ondansetron on atracurium-induced neuromuscular blockade. J Clin Anesth. ;5:399-403.

Kambam JR, Parris WCV, Franks JJ. The inhibitory effect of metoclopramide on plasma cholinesterase activity. Can J Anaesth. ;5:478-476.

Motamed C, Kirov K, Combes X. Effect of metoclopramide on mivacurium-induced neuromuscular block. Acta Anaesthesiol Scand. ;46:216-214.

Turner DR, Kao YJ, Bivona C. Neuromuscular block by succinylcholine following treatment with histamine type 2 antagonists or metoclopramide. Br J Anaesth. ;63:348-350.

El Ayass N, Hendrickx PH. Decreased mivacurium infusion rate and delayed neuromuscular recovery after metoclopramide: a randomized double blind placebo-controlled study. Eur J Anaesthesiol.. ;22:201-197.

Lepage L, Schiele F, Guequen R. Total cholinesterase in plasma: biological variations and references. Clin Chem. ;31:546-550.

Maddineni VR, Mirakhur RK. Prolonged neuromuscular block following mivacurium. Anesthesiology. ;78:1184-1181.

Petersen RS, Bailey PL, Kalameghan R. Prolonged neuromuscular block after mivacurium. Anesth Analg. ;76:194-196.

5dcdc0ac0e8825cd21bf58f1 rba Articles
Links & Downloads
2352-2291 (Electronic) 0104-0014 (Printed)
Braz J Anesthesiol ©2024 All rights reserved.

Braz J Anesthesiol

Share this page
Page Sections